A retrospective cohort study reveals that steroid use during acute SARS-CoV-2 infection is not associated with a reduced risk for pediatric long COVID. Treatment with corticosteroids during acute SARS ...

A 24-week treatment with bofanglutide for patients with type 2 diabetes showed meaningful glycemic control, weight loss, and improvements in cardiometabolic risk factors — reductions which seemed at ...

HHS terminates COVID-19 Emergency Use Authorizations for drugs, biologics, and devices, establishing transition timelines toward traditional FDA pathways.

Statewide doxycycline post-exposure prophylaxis implementation shows limited effectiveness against gonorrhea due to expanding antibiotic resistance. Rising tetracycline resistance compromises the ...

Metformin does not significantly reduce the risk for long COVID at 6 months in low-risk adults with high baseline immunity to the virus.

Better maternal CVH is associated with lower risk for offspring developmental delay at age 4 years, according to study results.

Survivors of hematologic cancers face a higher risk of developing cardiovascular disease, according to study results.

Younger adults are more susceptible to asymptomatic rhinovirus infections, whereas older adults are more likely to experience respiratory symptoms.

Metformin use may lower the risk for a composite of hospitalization, ED visits, or death in adult patients with acute COVID-19.

Patients with bronchiectasis and comorbid diabetes had more than double the incidence of cardiovascular disease than those without diabetes (53.5% vs 21.8%). Patients with bronchiectasis and diabetes ...